NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 2nd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings results on Wednesday, February, 12th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Zacks' consensus estimate of $1.68 by $0.05. The pharmacy operator earned $66.89 billion during the quarter, compared to analyst estimates of $64.01 billion. CVS Health had a net margin of 2.58% and a return on equity of 14.87%. The firm's revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the business earned $2.14 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for CVS Health.

CVS Health updated its FY20 earnings guidance on Wednesday, February, 12th. The company provided earnings per share guidance of $7.04-7.17 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.15.

23 brokers have issued 12 month target prices for CVS Health's shares. Their forecasts range from $61.00 to $109.00. On average, they expect CVS Health's stock price to reach $80.35 in the next twelve months. This suggests a possible upside of 24.9% from the stock's current price. View Analyst Price Targets for CVS Health.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 5 hold ratings, 16 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media stories about CVS stock have been trending neutral on Wednesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CVS Health earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave media coverage about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), QUALCOMM (QCOM) and Intel (INTC).

CVS Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Wealth Quarterback LLC (9.74%), State Street Corp (4.29%), FMR LLC (2.17%), Capital International Investors (1.90%), Geode Capital Management LLC (1.43%) and Franklin Resources Inc. (1.38%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, State Street Corp, Franklin Resources Inc., FMR LLC, Marshall Wace North America L.P., Caisse DE Depot ET Placement DU Quebec, FIL Ltd and Boston Partners. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Capital World Investors, LSV Asset Management, M&G Investment Management Ltd., PNC Financial Services Group Inc., Lord Abbett & CO. LLC, Janus Henderson Group PLC and Amundi Pioneer Asset Management Inc.. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $64.33.

CVS Health has a market capitalization of $83.90 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]